Financial Advisors, LLC Abbott Laboratories Transaction History

Financial Advisors, LLC

$524 Million
Q3 2024

A detailed history of Financial Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Financial Advisors, LLC holds 4,096 shares of ABT stock, worth $462,028. This represents 0.09% of its overall portfolio holdings.

Number of Shares

4,096

Previous 4,096 -0.0%

Holding current value

$462,028

Previous $425,000 9.65%

% of portfolio

0.09%

Previous 0.09%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	SELL	$90.19 - $110.4 $18,038 - $22,080	-200 Reduced 4.66%	4,096 $450,000
Q3 2023 Oct 10, 2023	SELL	$95.53 - $114.62 $19,106 - $22,924	-200 Reduced 4.45%	4,296 $416,000
Q2 2023 Aug 01, 2023	SELL	$100.78 - $112.29 $3,023 - $3,368	-30 Reduced 0.66%	4,496 $490,000
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $24,525 - $28,772	-258 Reduced 5.39%	4,526 $497,000
Q4 2021 Feb 11, 2022	SELL	$115.53 - $141.46 $4,852 - $5,941	-42 Reduced 0.87%	4,784 $673,000
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $16,099 - $17,810	138 Added 2.94%	4,826 $570,000
Q1 2021 Apr 16, 2021	BUY	$108.84 - $128.23 $3,265 - $3,846	30 Added 0.64%	4,688 $562,000
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $28,875 - $31,465	-275 Reduced 5.57%	4,658 $510,000
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $13,746 - $16,693	150 Added 3.14%	4,933 $537,000
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $20,542 - $30,038	-327 Reduced 6.4%	4,783 $377,000
Q4 2019 Feb 13, 2020	BUY	$78.51 - $87.4 $10,912 - $12,148	139 Added 2.8%	5,110 $444,000
Q3 2019 Nov 05, 2019	BUY	$81.84 - $88.74 $20,460 - $22,185	250 Added 5.3%	4,971 $416,000
Q2 2019 Jul 31, 2019	BUY	$72.88 - $85.0 $3,644 - $4,250	50 Added 1.07%	4,721 $397,000
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $306,230 - $346,915	4,671 New	4,671 $338,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $198B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Financial Advisors, LLC with notifications on news.

Account

Financial Advisors, LLC Abbott Laboratories Transaction History